Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists
SABS

SABS - SAB Biotherapeutics, Inc. Stock Price, Fair Value and News

3.04USD+0.04 (+1.33%)Delayed as of 17 Jul 2024, 10:52 am ET

Latest Insider Trading transactions for SABS

Datesorted ascendingNameBuy/Sell$ Value# SharesAvg. PriceTitle
2023-12-07 Premium
bought
Premium Premium PremiumChief Executive Officer
2023-11-30 Premium
bought
Premium Premium PremiumCHIEF FINANCIAL OFFICER
2023-11-29 Premium
bought
Premium Premium PremiumExecutive Chairman
2023-11-24 Premium
acquired
Premium Premium Premium-
2023-11-24 Premium
acquired
Premium Premium Premium-
2023-11-24 Premium
acquired
Premium Premium Premium-
2023-03-14 Premium
acquired
Premium Premium PremiumChief Medical Officer
2022-12-07 Premium
acquired
Premium Premium Premium-
2022-12-07 Premium
acquired
Premium Premium Premium-
2022-12-07 Premium
acquired
Premium Premium Premium-
2022-09-13 Premium
bought
Premium Premium Premium-
2022-09-07 Premium
bought
Premium Premium PremiumCHIEF EXECUTIVE OFFICER
2022-06-07 Premium
gifted
Premium Premium Premium-
2022-06-06 Premium
acquired
Premium Premium PremiumChief Medical Officer
2022-05-20 Premium
acquired
Premium Premium Premium-
2022-05-20 Premium
acquired
Premium Premium PremiumExecutive Chairman
2022-05-20 Premium
sold
Premium Premium PremiumExecutive Chairman
2021-10-26 Premium
sold
Premium Premium PremiumChief Financial Officer
2021-10-25 Premium
acquired
Premium Premium PremiumChief Financial Officer
2021-10-22 Premium
acquired
Premium Premium PremiumChief Medical Officer
2021-10-22 Premium
acquired
Premium Premium PremiumChief Executive Officer
2021-10-22 Premium
acquired
Premium Premium Premium-
2021-10-22 Premium
acquired
Premium Premium Premium-
2021-10-22 Premium
acquired
Premium Premium Premium-
2021-10-22 Premium
acquired
Premium Premium Premium-

Rows per page:

1–25 of 43